Herpes simplex virus-1 (HSV-1) infection of the cornea induces vascular endothelial growth factor A (VEGF-A)-dependent lymphangiogenesis. However, the extent to which HSV-1-induced corneal lymphangiogenesis impacts the adaptive immune response has not been characterized. Here, we used floxed VEGF-A mice to study the importance of newly created corneal lymphatic vessels in the host adaptive immune response to infection. Whereas the mice infected with the parental virus (strain SC16) exhibited robust corneal lymphangiogenesis, mice that received the recombinant virus (SC16 ICP0-Cre) that expresses Cre recombinase under the control of infected cell protein 0 (ICP0), an HSV-1 immediate-early gene, showed a significant reduction in lymphangiogenesis. There was no difference in virus recovered from the cornea of mice infected with SC16 vs SC16 ICP0-Cre. However, viral loads were significantly elevated in the trigeminal ganglia (TG) of mice with reduced corneal lymphangiogenesis. The increase in viral titer correlated with a significant loss of HSV-1-specific CD8 + T cells that traffic to the TG of mice infected with the recombinant virus. Intrastromal delivery of size-exclusion dye (fluorescein isothiocyanate-dextran) revealed a time-dependent defect in the ability of the lymphatic vessels in SC16 ICP0-Cre-infected mice to transport soluble antigen from the cornea to the draining lymph nodes. We interpret these results to suggest that the newly created lymphatic vessels in the cornea driven by HSV-1 infection are critical in the delivery of soluble viral antigen to the draining lymph node and subsequent development of the CD8 + T-cell response to HSV-1.
Although lymphatic vessels are an integral component of our circulatory system alongside blood vessels, the molecular underpinnings of their development and the mechanism of their interaction with cells of the immune system have been characterized only in the past decade. 1 While blood vessels supply nutrients, oxygen and macromolecules to the tissues, lymphatic vessels drain interstitial fluids, antigens and antigen-presenting cells (APCs) from the periphery to the regional lymph nodes, and ultimately back into circulation. Lymphatic vessels reside throughout our body alongside the blood vasculature including the meninges of the central nervous system 2 and the limbus of the cornea. 3 Despite the essential role of lymphatic vessels, aberrant development or function can be detrimental including metastasis of tumor cells. 4 In the anterior segment of the eye, the blood and lymphatic vessels are absent in the cornea, but are present in the limbal aspect and the adjacent subconjunctiva. 3 This immune-privilege status of the cornea is a combination of several different factors including avascularity, the presence of soluble vascular endothelial growth factor receptor-1 (VEGFR-1) receptors, 5 low major histocompatibility (MHC) class II-expressing cells, 6 expression of VEGFR-3 receptors on epithelial cells 7 and FAS-ligand manifestation on epithelial and endothelial cells. 8 Trauma to or infection of the cornea can lead to the disruption of this unique status and threaten visual acuity. Typical manifestations of this disruption involve hem-and lymphangiogenesis and inflammation.
The generation of the adaptive immune response to pathogens that infect the eye involves a series of cellular and molecular events. Mechanistically, the corneal APCs are activated and express the CC chemokine receptor 7, which senses the chemotactic gradient of the CC chemokine ligand 21 expressed by the afferent lymphatic vessels. 9, 10 The cells then crawl within the lymphatic vessel and use the directionality of lymph flow to arrive in the adjacent lymph node where antigen presentation in the context of MHC class I or II molecules to resident T cells. 10 The activated T cells then migrate via efferent lymphatics and arrive at the site of infection via the blood vasculature.
Herpes simplex virus-1 (HSV-1) is a neurotropic virus with a high prevalence in the human population. 11 After mucoepithelial infection, the virus invades the trigeminal ganglia (TG) and establishes a latent state for the lifetime of the host. 12 Although lethal encephalitis is not a typical manifestation, stress-induced reactivation of the virus manifests infection of the cornea via anterograde transportation from the ophthalmic branch of the TG. 13 Recurring bouts of corneal infection can lead to a pathologic state known as herpetic stromal keratitis (HSK). 14 HSK is manifested by opacity and neovascularization of the cornea. In a mouse model of HSK, corneal HSV-1 infection induces lymphangiogenesis in a VEGF-A-dependent manner. 15 This observation is in sharp contrast to inflammatory lymphangiogenesis during bacterial infection, where VEGF-C has the primary role. 16 Furthermore, HSV-1 induces the expression of VEGF-A through infected cell protein-4 (ICP-4) activation of the VEGF-A promoter in the infected cell. 17 Notably, the infected cells are the predominant source of VEGF-A, whereas infiltrating macrophages, polymorphonuclear cells, and other bystander cells have a minimal contribution to lymphangiogenesis. 15, 17 Despite the ability of viral-induced genesis of the lymphatic vessels to drain soluble antigens from the cornea, 15 the extent to which this process influences the adaptive immune response to the pathogen is unknown.
Here, we demonstrate the lymphatic vessels that extend into the central cornea following HSV-1 infection have a profound impact on the generation of HSV-1-specific CD8 + T cells. This process occurs independent of DC trafficking and in a manner that allows soluble viral antigens to migrate from the cornea to the draining mandibular lymph nodes (MLNs).
RESULTS

Suppression of corneal lymphangiogenesis because of the reduced expression of VEGF-A
HSV-1 infection of cornea induces lymphangiogenesis in a VEGF-Adependent manner. 15 However, the role of HSV-1-induced corneal lymphangiogenesis on the host adaptive immune response has not been determined. HSV-1 infection of VEGF-A flox/flox mice with the parental virus (strain SC16) induced profound corneal lymphatic vessel genesis (Figures 1a and b ). By comparison, VEGF-A flox/flox mice infected with strain SC16 ICP0-Cre did not induce corneal lymphangiogenesis up to 30 days postinfection (p.i.) (Figures 1a and b). Consistent with previous findings, using the same model to measure corneal VEGF-A expression 24 h p.i., 17 VEGF-A protein expression was significantly reduced in VEGF-A flox/flox mice infected with the recombinant virus as compared with the parental virus at day 7 p.i. (Figure 1c ). The stark suppression of corneal lymphangiogenesis was not because of the inability of the recombinant virus to replicate in the epithelium as there was no difference in the amount of infectious virus recovered in the cornea when compared with the parental virus ( Figure 1d ). Intrastromal administration of exogenous recombinant VEGF-A in SC16 ICP0-Cre-infected VEGF-A flox/flox mice partially rescued lymphangiogenesis (Figures 1e-g). Furthermore, the phenotype could not be attributed to the inability of the recombinant virus to induce VEGF-A expression as SC16 ICP0-Cre-induced corneal lymphangiogenesis in wild-type (WT) C57BL/6 mice comparable to that of the parental SC16 virus (Figures 2a and b) . Moreover, the recombinant virus was able to replicate efficiently in the WT corneas similar to levels found in the VEGF-A flox/flox mice ( Figure 2c ). Hence, the data suggest the loss of VEGF-A expression after HSV-1 infection prevents corneal lymphangiogenesis.
Cellular infiltration in the cornea
To determine if the loss of corneal lymphangiogenesis following HSV-1 infection reduces the infiltration of leukocytes in the cornea, corneas were analyzed for leukocyte content at day 7 p.i. The results show a significant reduction in the infiltration of CD8 + T cells in the mice infected with the recombinant virus as compared with parental virus-infected VEGF-A flox/flox mice ( Figure 3b Figure 3f ). Whereas we cannot rule out the contribution of CD8 + T cells to corneal lymphangiogenesis at a later time point as described previously, 18 changes in corneal lymphangiogenesis in the SC16 ICP0-Cre-infected mice are not reflected in the composition of other resident leukocytes.
Abrogated host adaptive immune response to HSV-1 following the loss of corneal lymphangiogenesis CD8 + T cells contribute to viral surveillance during acute ocular infection 19 and prevent HSV-1 reactivation from the TGs following latent infection. 20 Time-course analysis of viral titers in the TGs of the VEGF-A flox/flox mice revealed an elevated lytic virus replication at day 8 p.i. in SC16 ICP0-Cre-infected mice as compared with the parental SC16-infected mice ( Supplementary Figure 1a ). Suppressed corneal lymphangiogenesis and elevated viral titers in the TGs of the VEGF-A flox/flox mice infected with the recombinant virus led us to hypothesize that the viral-specific adaptive immune response was diminished in these mice. Time-course flow cytometric analysis of CD4 + , CD8 + and HSV-1-specific CD8 + T cells revealed no discernable differences through day 5 p.i. in the MLN comparing mice infected with the parental to the recombinant virus (Figures 4a-c). However, a significant loss of total T cells was apparent in the mice infected with the recombinant virus by day 7 p.i. (Figures 4a-c ). This reduction correlated with a significant loss of HSV-1-specific CD8 + T cells in the TG at day 7 p.i. and a trend in the loss of total CD4 + or CD8 + T cells (Figures 4d-f ). Thus, the loss in HSV-1-specific CD8 + T cells recruited to the TGs correlated with the drop in clonal expansion of these cells in the draining lymph node from day 5 to day 7 p.i.
CD8 + T cells in the TGs are functional CD8 + T cells patrol latently infected TGs and suppress viral reactivation by interferon-γ (IFN-γ) production. 20 To rule out the possibility that the CD8 + T cells in the TGs of mice infected with the recombinant virus were dysfunctional, CD8 + T cells isolated from the TGs of the mice infected with either the parental or the recombinant virus at day 8 p.i. were cultured and stimulated with phorbol myristate acetate/ionomycin or vehicle control. The cells were then harvested and intracellular staining of IFN-γ was performed followed by surface staining of CD45, CD3 and CD8 antigens. Flow cytometric analysis revealed that while vehicle-stimulated T cells induced minimal IFN-γ production, phorbol myristate acetate/ionomycin stimulation of the T cells induced IFN-γ production that was equivalent between T cells obtained from SC16 parental vs recombinant SC16 ICP0-Cre virus-infected animals ( Supplementary  Figures 1b and c) . Thus, changes in viral surveillance between parental vs recombinant HSV-1-infected mice was not because of aberrant CD8 + T-cell function as measured by IFN-γ expression.
Defect in antigen delivery in the absence of corneal lymphangiogenesis
In addition to the transport of lymph, interstitial fluids and cells by the afferent lymphatic vessels, the delivery of soluble molecules or antigens from tissues to the draining lymph nodes to be surveyed by T lymphocytes is a major contributor in eliciting an adaptive immune response. 1 Molecules o70 kDa in size can freely migrate into the afferent lymphatic vessels and reach the lymph node sinuses within minutes. 21 Presentation of the antigenic epitopes by MHC molecules through APCs such as dendritic cells (DCs) to the T cells is a requisite for T-cell clonal expansion. To interrogate the possibility of a difference in viral antigen migration to the MLN from the cornea, intrastromal injection of 1 μg size-exclusion fluorescein isothiocyanate (FITC)-dextran (70 kDa) was conducted in uninfected mice or mice infected with SC16 or ICP0-Cre at day 6 p.i. (Figure 5a ). Corneal haze during the injection confirmed the tissue distribution of the dye and success of the procedure. The MLNs were harvested 18 h postinjection. Flow cytometric analysis revealed that there were no difference in the total number of activated DCs (CD45 + CD11c + , MHC class II + and CD86 + ) in the MLN comparing the SC16 and ICP0-Cre-infected mice (Figures 5b and d ). However, a significantly lower number of total FITC-dextran + cells and activated DCs that were FITC-dextran + were detected in the mice infected with ICP0-Cre (Figures 5b,c and e). At an earlier time point (day 4 p.i.), these differences were not detected ( Supplementary Figures 2a-d) . We interpret the data to suggest that (i) there is an apparent defect in the transportation of soluble antigen from the cornea to the MLN over time, (ii) activated DC do not sustain soluble antigen in the SC16-Cre recombinant virus-infected mice or (iii) there are different routes of antigen delivery that include cell-dependent and cell-independent mechanisms. As corneal lymphangiogenesis is not readily detected in the cornea separate from the limbus until days 5-6 p.i. at this infectious inoculum, it is possible the earlier time point reflects another distribution process for delivery of antigen from the cornea to the MLN.
DCs show no defect in migration to the draining lymph node from corneas with attenuated lymphangiogenesis
Resident corneal DCs can engulf soluble antigens and migrate to the MLN where they present antigens to the T cells in the context of MHC. 22 Hence, the ability of these migratory DCs to reach the MLN can have a significant effect on T-cell activation. To examine the ability of the resident corneal DCs to become migratory and reach the MLN after infection, we used an FITC-painting model that has been reported previously to track the migration of DCs. 23 When FITC was applied to the cornea 6 days p.i., there was no difference in the total number of CD45 + CD11c + DCs residing in the cornea 18 h after FITC-paint comparing the SC16 and ICP0-Cre-infected mice ( Supplementary Figures 3a and b) . Similarly, no appreciable differences were observed in the total number of FITC + DCs in the MLN comparing the two groups of HSV-1-infected mice ( Supplementary  Figures 3a and b) . These results suggest the lack of corneal lymphangiogenesis of SC16 ICP0-Cre-infected mice does not significantly impact on the migration of resident DCs from the cornea to the MLN. By extension, it is also likely the contribution of the corneal DCs to clonal expansion of T cells in the MLN is considerably less than MLN DCs that collect soluble antigen transported from the afferent lymphatics in the MLN.
Proliferation of exogenous T cells in vivo
To further substantiate the notion that the loss of T-cell expansion in the MLN in the absence of corneal lymphangiognesis is owing to the lack of adequate soluble antigen distribution, isolated HSV-1 glycoprotein B (gB)-specific T-cell receptor CD8 + T cells from HSV-1-infected gB-I.1 T-cell transgenic mice were labeled with carboxyfluorescein succinimidyl ester (CFSE), and transferred into VEGF-A flox/flox mice at day 3 p.i. (Figure 6a ). Four days after transfer (day 7 p.i.), the MLNs were harvested, processed and analyzed for CSFE-labeled T-cell proliferation. Flow cytometric analysis revealed that most of the transferred HSV-1gB-specific CD8 + T cells did not survive in the naive host and a similar number migrated to the MLN in SC16 and SC16 ICP0-Cre-infected mice (Figure 6b ). Although a majority of those cells underwent proliferation in the SC16-infected hosts, a significant number of them did not proliferate (CSFE hi ) or modestly proliferated (CSFE mid ) in the SC16 ICP0-Cre-infected hosts (Figures 6c-e ). Nearly equivalent numbers of transferred HSV-1gB-specific T-cell receptor CD8 + T cells did proliferate comparing the SC16 to SC16 ICPO-Cre-infected recipients (Figure 6f ). These data underscore the deficiency in soluble antigen transportation from the cornea to the draining lymph nodes or antigen presentation in the MLN that leads to a reduction in T-cell expansion at this time point in the SC16 ICP0-Cre-infected mice. However, it does suggest there is a sufficient number of antigenexpressing DC to drive some proliferation at least for the exogenous transgenic T-cell receptor HSV-1gB-specific CD8 + T cells in SC16 ICP0-Cre-infected mice at a rate similar to that found in the SC16-infected recipients.
T-cell survival factors in the MLN
In order for T cells to undergo clonal expansion, proliferation and maintenance, several cytokines such as interleukin (IL)-2, IL-7, IL-12 p70 24 and IL-15 25 have a critical role. To determine if there were differences in expression of these key cytokines in the MLN of the VEGF-A flox/flox mice infected with the parental or recombinant virus, MLNs were harvested at day 6 p.i. from SC16 and SC16 ICP0-Creinfected mice, processed and analyzed for cytokine content. The results show a significant increase in expression of IL-2, IL-7, IL-12 p70 and IL-15 comparing infected to uninfected mice ( Supplementary  Figure 4 ). However, there were no appreciable differences in the level of IL-2, IL-7 or IL-15 found comparing SC16 and ICP0-Cre-infected mice ( Supplementary Figure 4) . Of note, there was a modest but significant reduction in IL-12 p70 content in the MLN of SC16 ICP0-Cre-infected mice in comparison with mice inoculated with the parental SC16 virus.
Fibroblastic reticular cells in the MLN
Fibroblastic reticular cells (FRCs) are specialized stromal cells found in secondary lymphoid organs including lymph nodes that have critical roles in the immune response. 26 To determine the effect of ablated corneal lymphangiogenesis in total cellularity of FRCs, we performed flow cytometric analysis of FRCs (CD31 − PDPN + (podoplanin)) as well as blood endothelial cells (BECs) and lymphatic endothelial cells (LECs) in the MLN at days 5 and 7 p.i. (Figure 7) . Whereas no appreciable differences in lymph node BECs, LECs and FRCs were detected comparing the parental vs recombinant virus-infected VEGF-A flox/flox mice at day 5 p.i. (Figures 7a and b) , FRC numbers were reduced over 50% in the recombinant virus-infected mice at day 7 p.i. (Figures 7c and d) . Although a trend in the reduction of LEC numbers was observed in recombinant virus-infected mice, it did not reach statistical significance at day 7 p.i. (Figure 7d ).
DISCUSSION
The avascular nature of the cornea is a requisite for optimal visual acuity, 5 which is indispensible for its immune-privilege status. During HSV-1 infection, not only does the virus induce a proinflammatory host response it also elicits the genesis of lymphatic vessels from the pre-existing lymphatic plexus in the limbal region. 15 This lymphangiogenic response persists well beyond the resolution of infection. 15 However, the extent to which these newly created lymphatic vessels impact on the generation of the adaptive immune response to the pathogen is not known. Herein, we used floxed VEGF-A mice to study the effects of VEGF-A ablation following HSV-1 infection on the lymphangiogenic response in the cornea and potential downstream effects of the host immune response. The loss of lymphangiogenesis during acute HSV-1 infection attenuated the viralspecific CD8 + T-cell-mediated immune response in the draining MLN, which correlated with an increase in infectious virus recovered from the TG, a site where the virus infects following ocular inoculation. The stark suppression of corneal lymphangiogenesis in the absence of VEGF-A during HSV-1 infection corroborates previous findings that reported the blockade of VEGF-A/R2 axis prevents corneal lymphangiogenesis. 15 Although inflammatory cytokines such as tumor necrosis factor-α and IL-6 induce corneal lymphangiogenesis in response to HSV-1 infection, 25 these likely occur through paracrine production of VEGF-A. 27, 28 Moreover, the infected cells are the predominant source of VEGF-A during HSV-1 infection 15, 17 and therefore such findings support the idea that the loss of HSV-1-induced VEGF-A production abrogates the genesis of lymphatic vessels. Inflammatory lymphangiogenesis during wound healing and tumorigenesis primarily depend on VEGF-C production by infiltrating macrophages or the tumor cells themselves acting via VEGFR-3 receptors. 1 However, HSV-1-induced corneal lymphangiogenesis occurs independent of infiltrating macrophages. 15 Consistent with this observation, we did not observe any appreciable differences in the total number of infiltrating macrophages/monocytes in the cornea following HSV-1 infection comparing the SC16 and SC16 ICP0-Cre-infected VEGF-A flox/flox mice even though there was a loss of lymphatic vessel genesis in the SC16 ICP0-Cre-infected mice. Along these lines, the loss of corneal lymphangiogenesis in SC16 ICP0-Creinfected mice did not impact HSV-1 replication in the cornea despite the loss of infiltrating CD8 + T cells. However, CD8 + T cells are not the only cell type that control lytic viral replication as inflammatory monocytes are relegated this role early during infection in the cornea. 29 Antigen-specific CD8 + T cells are critical in preventing HSV-1 reactivation from the dormant state in the TG. 20 We observed a significant increase in the viral titers in the TG at day 8 p.i. following the loss of HSV-1-induced corneal lymphangiogenesis, which correlated with a significant loss of HSV-1-specific T cells in the draining lymph node and TG at day 7 p.i. Timecourse analysis of the dynamics of the T cells in the lymph node following HSV-1 infection revealed no differences up to day 5 p.i. Given the low dosage of infection (200 pore-forming unit (PFU)), lymphatic vessel genesis is not readily detected in the cornea until day 7 p.i. and thus may explain the lack of any significant impact on T-cell responses in the draining lymph node at earlier time points.
Not only do the lymphatic vessels transport cells and lymph from the tissues to the lymph nodes, they also provide conduits for the soluble antigens to diffuse from the site of infection to be transported to the nodes for presentation by the resident APCs and induce subsequent proliferation of T cells. 30 We observed a profound loss of T cells in the MLN by day 7 p.i. in mice infected with the recombinant virus. We interpret our results to suggest that the observed phenotype was, at least in part, due to the inefficient drainage of soluble antigen from the cornea in the absence of newly formed lymphatic vessels. Following activation, tissue-resident APCs such as DCs migrate toward the 'button-like' afferent lymphatics 31 by upregulating CC chemokine receptor 7 expression and sensing a chemotactic CC chemokine ligand 21 expressed on LECs. 9, 10 Once inside the collecting lymphatic vessel, the APCs sense the lymph flow and arrive in the lymph node parenchyma via sinuses where they cross-present to other APCs. However, our data revealed no apparent defect in the migration of the corneal DCs to the MLN, regardless of the presence or absence of newly acquired corneal lymphatic vessels in response to HSV-1 infection. This observation is consistent with the previous demonstration that the graft-derived DCs migrated to the draining MLN after cornea transplant despite the absence of corneal lymphangiogenesis. 32 A recent study suggest that migratory DCs are dispensable for immunity, whereas lymph node-resident DCs tend to drive the immune response. 33 Such findings are consistent with our results in that soluble antigen presumably taken up by resident MLN DCs was compromised, whereas DC trafficking from the cornea to the MLN was not affected. Although VEGF-A inhibits DC maturation in steady state 34 and in the tumor microenvironment, 35 such effects have not been reported during HSV-1 infection. Moreover, the role of VEGF-A in DC maturation appears to be context-dependent, as it does not inhibit DC maturation in a proinflammatory setting. 36 HSV-1 infection of corneal epithelial cells induces the production of proinflammatory cytokines. 25, 37 Whether VEGF-A production under such setting inhibits DC maturation has not yet been determined. We posit since the antigen transportation efficiency and the dynamics of the T cells in the MLN at day 5 p.i. are not different comparing the SC16 or ICP0-Cre-infected VEGF-A flox/flox mice, it appears that the inefficient transportation of viral antigen at day 7 p.i. in the absence of corneal lymphangiogenesis influences T-cell activation, clonal expansion and/or differentiation. This conclusion is supported by data that show a significant proportion of exogenous HSV-1-specific CD8 + T cells did not proliferate in the MLN of VEGF-A flox/flox mice infected with the recombinant virus.
The loss of T-cell clonal expansion in SC16 ICP0-Cre-infected VEGF-A flox/flox mice is further supported by our finding of the reduced production/availability of IL-12p(70), a third signal required for T-cell activation. Such differences in MLN IL-12 p70 level comparing mice inoculated with the parental or the recombinant HSV-1 is currently unclear. However, DCs are the major source of IL-12 p70 during inflammation 38 such that deficient crosspresentation in DCs in the absence of corneal lymphangiogenesis is a possible explanation for the reduced IL-12 p70 production. Reciprocally, diminished IL-12 p70 levels could negatively affect DC cross-presentation. 39 Furthermore, it was also found that the loss of lymph node FRCs paralleled the loss of T-cell clonal expansion in the SC16 ICP0-Cre VEGF-A flox/flox -infected mice. During infection, the FRCs proliferate and contribute to the clonal expansion of antigenspecific T cells. 26 In this study, the expansion of lymph node FRCs ceases at the time of loss of corneal lymphangiogenesis. However, such loss in the expansion of FRCs may occur independent of the loss of inflammatory cues including VEGF-A, as trapping of naive lymphocytes within the lymph nodes by resident and migratory DCs is sufficient to stimulate FRCs expansion. 40 Nevertheless, activated T cells may also enhance FRCs expansion, although they are dispensable early on during inflammation. 40 Overall, a combination of a loss of antigen exposure and FRCs within the draining lymph node likely results in an unfavorable outcome in T-cell expansion at the latter time point of acute infection.
The current treatment regimen for HSK includes the use of acyclovir with or without topical corticosteroids. 41 However, such intervention comes with serious side effects including glaucoma and cataract. 14 Although the anti-VEGF-A agent aflibercept (VEGF-trap) has clinical efficacy in blocking corneal hemangiogenesis in rabbits, 42 and wound healing in mice, 43 its effectiveness in treating corneal neovascularization during HSK has not been reported in mammals including man. Interestingly, aflibercept did not reduce lymphangiogenesis in a mouse model of corneal transplant following suture placement. 43 However, subconjunctival injection of anti-VEGF-A monoclonal antibody blocked HSV-1-induced corneal lymphangiogenesis in mice. 15 Taken together, the data indicate that the dynamics of corneal lymphangiogenesis is dependent on the nature of the insult.
HSK patients who undergo corneal transplant have a high risk of allograft rejection 44 likely mediated by the activation of non-selfspecific CD8 + T cells. Our data suggest that the newly created lymphatic vessels in the cornea in response to HSV-1 infection may not only have a profound impact on the generation of HSV-1-specific CD8 + T cells but may also provoke subsequent graft rejection following corneal transplant. Collectively, the data suggest that specific therapies that target lymphangiogenesis are critical for the management of sight-threatening disease such as HSK.
METHODS
Mice and infection
A breeder pair of VEGF-A flox/flox mice in which the VEGF-A allele is flanked by 32 base pair lox P sites was graciously provided by Genentech (South San Francisco, CA, USA). HSV gB T-I.1 T-cell receptor transgenic mice, received from Dr Francis Carbone (University of Melbourne, Melbourne, VIC, Australia) 45 and VEGF-A flox/flox mice were maintained at Dean McGee Eye Institute (Oklahoma City, OK, USA). C57BL6/J mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Epithelial debridement of the cornea was conducted on anesthetized, 6-8-week-old male and female mice using a 25 G needle. The tear film was blotted, and the cornea was inoculated with 200 plaque-forming units (PFUs) of HSV-1 in 3 μl volume of phosphatebuffered saline (PBS). The parental HSV-1 (strain SC16) was a gift from Dr Weiming Yuan (University of Southern California, Los Angeles, CA, USA). The recombinant HSV-1 (strain SC16 ICP0-Cre) that expresses Cre recombinase under ICP0 promoter was a gift from Dr S Efstathiou (University of Cambridge, Cambridge, UK). 46 The sample size for each experiment was chosen based on our previous publications. 15, 17, 25 Ethics statement 
Immunofluorescence microscopy and image analysis
Anesthetized mice were perfused with 1 × PBS, and corneas were excised under a dissection microscope. Corneas were fixed in 4% paraformaldehyde (Sigma-Aldrich, St Louis, MO, USA) for 30 min at 4°C, followed by three washes, 15 min each in 1 × PBS containing 1% Triton X-100 (Alfa Aesar, Haverhill, MA, USA) (PBST) at room temperature (RT). The corneas were then blocked in 10% normal donkey serum (Jackson Immunoresearch, West Grove, PA, USA; Code: 017-000-121) overnight at 4°C, followed by the addition of 1:100 rabbit anti-mouse LYVE-1 (Abcam, Cambridge, MA, USA; catalog no. ab14917) and another overnight incubation at 4°C. The corneas were then washed 5 × for 30 min each in 0.1% PBST at RT and further incubated overnight with 1:100 donkey anti-rabbit Alexa Fluor 488 (Jackson Immunoresearch; catalog no. ab96919) at 4°C. The following day, the corneas were washed 5 × for 30 min each in 0.1% PBST at RT, and mounted on glass slide following radial cuts to divide the cornea into four equal quadrants. The tissue was then imaged using a laser-scanning confocal microscope, IX81-FV-500 (Olympus, Waltham, MA, USA) as described previously. 15 The Z-stacked images containing the LYVE-1 signals were quantified using MetaMorph Imaging Suite v.7.0 (MDS Analytical Technologies, Sunnyvale, CA, USA).
Cytokine/growth factor measurement
Corneas and sub-MLNs were homogenized with a Tissuemiser (Fisher Scientific, Pittsburgh, PA, USA) in the presence of 1 × Calbiochem protease inhibitor cocktail set I (EMD Millipore, Billerica, MA, USA ) in 1x PBS. The tissue homogenates were centrifuged at 10 000 g for 3 min at 4°C. Supernatants were collected and assessed for VEGF-A content using a standard ELISA Kit (R&D Systems, Minneapolis, MN, USA) or IL-2, IL-7, IL-12 p70 and IL-15 content using a Multiplex Suspension Array Kit (EMD Millipore). VEGF-A ELISA plates were analyzed using a CLARIO Star Microplate Reader (BMG Labtech, Cary, NC, USA). The luminex x-map bead-based multiplex assays were analyzed using a Bio-plex 200 System (Bio-Rad, Hercules, CA, USA).
Viral titers
Corneas, TGs and brains were harvested at the indicated times p.i., homogenized, centrifuged (10 000 g, 90 s) and assayed for viral content by plaque assay using Vero cell (American Type Culture Collection, Manassas, VA, USA) monolayers as described previously. 47 Exogenous VEGF-A experiment VEGF-A flox/flox mice were anesthetized, and 1μl (10 ng) of either recombinant VEGF-A (Prospec, Rehovot, Israel) or ultrapure DNase/RNase-free distilled water (vehicle) (Life Technologies, Carlsbad, CA, USA) were injected into the stromal layer of the cornea using a gas-powered microinjection system as described previously. 15, 25 Immediately following the injection, the mice were inoculated with 200 PFUs of SC16 ICP0-Cre. On day 2 p.i., the mice were injected again with recombinant VEGF-A or vehicle, and on day 7 p.i., the mice were killed to harvest corneas for whole mount.
Flow cytometry
The MLNs, TGs and spleens were harvested as indicated, and processed to make single-cell suspensions in RPMI-1640 media (Life Technologies). The lymph nodes and spleen were dissociated using a 3 ml plunger head on a 40 μm filter (Fisher Scientific). The TGs were processed in a dounce homogenizer (Fisher Scientific). The spleen homogenates were subjected to red blood cell lysis in 0.84% ammonium chloride in potassium bicarbonate (Sigma-Aldrich). For stromal cell analysis, MLNs were dissected into small pieces, and digested in RPMI-1640 media in the presence of 1 mg ml − 1 Collagenase Type IV (Sigma-Aldrich) by incubating at 37°C for 30 min. The single-cell suspensions were filtered through a 40 μm filter to remove remaining unprocessed tissue before staining. Antibodies used to label cells of interest included rat anti-mouse CD45 eFlour-450 (eBioscience, San Diego, CA, USA, catalog no. 48-0451), rat antimouse CD3e FITC (eBioscience; catalog no. 11-0031), rat anti-mouse CD4 APC (eBioscience; catalog no. 17-0041), rat anti-mouse CD8 phycoerythrin (eBioscience; catalog no. 12-0081), rat anti-mouse CD8a FITC (eBioscience; catalog no. 11-0081), rat anti-mouse IFN-γ APC (eBioscience; catalog no. 17-7311 ), rat anti-mouse CD11c PeCy7 (eBioscience; catalog no. 25-0114), rat anti-mouse CD86 PE (Tonbo Biosciences, San Diego, CA, USA; catalog no. 50-0862), rat anti-mouse MHCII APC (eBioscience; catalog no. 20-5321), rat anti-mouse CD31 APC (eBioscience; catalog no. 17-0311), rat anti-mouse PDPN PE (eBioscience, catalog no. 12-5381) and MHC I tetramer phycoerythrin (National Institute of Allergy and Infectious Diseases Tetramer Core Facility, Emory University Vaccine Center, Atlanta, GA, USA). The labeled cells were fixed in 1% paraformaldehyde overnight at 4°C. The following day the samples were resuspended in 1% PBS, 1% bovine serum albumin solution and analyzed using a MACS flow cytometer (Miltenyi Biotec, San Diego, CA, USA).
In vitro T-cell assay
CD8 + T cells were isolated from the TGs of VEGF-A flox/flox mice at day 7 p.i. using the MACS column-based CD8a T-Cell Isolation Kit (Miltenyi Biotec). Approximately 5 × 10 5 isolated CD8 + T cells were then cultured in a 24-well plate in the presence or absence of phorbol myristate acetate/ionomycin (EMD Millipore) or dimethyl sulfoxide (Sigma-Aldrich) vehicle as described previously. 47 The cells were then harvested and intracellularly stained with anti-IFN-γ APC (eBioscience; catalog no. 17-7311) followed by surface stain for CD3, CD8 and CD45 antigen expression 3 h poststimulation.
FITC-dextran assay
VEGF-A flox/flox mice were subjected to intrastromal injection of 1μg sizeexclusion (70 kDa) FITC-dextran dye (Molecular Probes, Eugene, OR, USA) at days 4 or 6 p.i. at a concentration of 10 mg ml − 1 as described previously. 15 Briefly, 1 μl of the FITC-dextran solution was injected into the stroma of the cornea using a glass needle on a gas-powered microinjection system, PM2000 (MicroData Instrument Inc., Plainfield, NJ, USA) under an ophthalmic surgical microscope (Carl Zeiss Inc., Thornwood, NY, USA). Draining MLNs were harvested 18 h postinjection and processed to generate single-cell suspensions for subsequent flow cytometric analysis.
FITC-paint assay
To track the migration of DCs from the site of infection to the draining MLNs, uninfected or infected VEGF-A flox/flox mice were anesthetized, and their corneas were painted with 2 μl of an 1% FITC solution prepared in 1:1 volume of acetone and dibutyl phthalate (Sigma-Aldrich) at day 6 p.i. as described previously. 23 After 18 h, the mice were killed, MLN harvested and processed for flow cytometric analysis of FITC + DCs.
Adoptive transfer experiment
gB T-I.1 transgenic mice were infected with 500 PFUs of HSV-1 (strain McKrae)/cornea. At day 7 p.i., the spleen and MLNs were harvested. CD8 + T cells were isolated from the samples using a CD8a T-Cell Isolation Kit (Miltenyi Biotec). The isolated cells were labeled with CFSE (Sigma-Aldrich) and 1 × 10 6 live cells were transferred to VEGF-A flox/flox mice at day 3 p.i. via retro-orbital injection. At 96 h postinjection, the mice were killed, and MLNs and spleen were harvested/processed for flow cytometry.
Statistics
Experiments involving comparison between three groups were analyzed using one-way analysis of variance followed by Tukey's multiple comparison test. Comparisons between two groups were analyzed using unpaired two-sided Student's t-test. Survival curve was analyzed by Mantel-Cox (log-rank test) method. All statistical analysis was performed with Prism 6 (GraphPad 6.0; GraphPad, La Jolla, CA, USA).
